menu
    • menu

    Company profile for OS Therapies

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OS Therapies (OST) is a clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS). OS Therapies was launched to meet significant unmet need for new treatments in cancers of the bone in kids and adults. Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and...
    OS Therapies (OST) is a clinical stage therapeutic company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS). OS Therapies was launched to meet significant unmet need for new treatments in cancers of the bone in kids and adults. Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. At OST, we are trying to answer the calls for new treatments, considering there have been no new treatments for OS in over 30 years.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OS TherapiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    INOVA Center for Personalized Health Building D, 7th Floor 3225 Gallows Roa...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ostherapies.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/os-therapies/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    US FDA Grants End of Phase 2 Meeting to OS Therapies
    US FDA Grants End of Phase 2 Meeting to OS Therapies

    03 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250703693366/en/OS-Therapies-Granted-End-of-Phase-2-Meeting-by-US-FDA-for-OST-HER2-Program-in-the-Prevention-or-Delay-of-Recurrent-Fully-Resected-Pulmonary-Metastatic-Osteosarcoma

    BUSINESSWIRE
    03 Jul 2025
    Share Share
    OS Therapies Reports Strong 1-Year OST-HER2 Trial Data
    OS Therapies Reports Strong 1-Year OST-HER2 Trial Data

    30 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250630174522/en/OS-Therapies-Presents-Statistically-Significantly-Positive-1-Year-Event-Free-Survival-Overall-Survival-and-Safety-Clinical-Data-Updates-for-OST-HER2-at-the-MIB-Agents-Factor-Osteosarcoma-Conference

    BUSINESSWIRE
    30 Jun 2025
    Share Share
    OS Therapies Gets FDA Feedback on OST-HER2 Approval Path
    OS Therapies Gets FDA Feedback on OST-HER2 Approval Path

    24 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250624414411/en/OS-Therapies-Receives-Positive-FDA-Meeting-Feedback-on-Regulatory-Pathway-for-Accelerated-Approval-of-OST-HER2-in-the-Prevention-or-Delay-of-Recurrent-Fully-Resected-Pediatric-Lung-Metastatic-Osteosarcoma

    BUSINESSWIRE
    24 Jun 2025
    Share Share
    OS Therapies Announces Warrant Exercise & Exchange Offer
    OS Therapies Announces Warrant Exercise & Exchange Offer

    23 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250623789974/en/OS-Therapies-Announces-Warrant-Exercise-Inducement-Exchange-Offer

    BUSINESSWIRE
    23 Jun 2025
    Share Share
    OS Therapies Seeks RMAT Designation for OST-HER2 in Lung Metastat
    OS Therapies Seeks RMAT Designation for OST-HER2 in Lung Metastat

    06 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250602523393/en/OS-Therapies-Submits-Request-for-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-to-U.S.-FDA-for-OST-HER2-in-the-Prevention-of-Metastases-in-Recurrent-Fully-Resected-Lung-Metastatic-Pediatric-Osteosarcoma

    BUSINESSWIRE
    06 Jun 2025
    Share Share
    OS Therapies Reports Q1 2025 Results and Business Update
    OS Therapies Reports Q1 2025 Results and Business Update

    16 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250516302762/en/OS-Therapies-Reports-First-Quarter-2025-Financial-Results-and-Provides-Business-Update

    BUSINESSWIRE
    16 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search